Payment overview · 2025
General Payments
We did not find matching Open Payments records for this doctor in the selected program year.
Healthcare provider profile · identity verified
Internal Medicine · PORT CHARLOTTE, FL · NPI 1346396801
Verified facts
We did not find matching Open Payments records for this doctor in 2025.
These records do not establish that a payment influenced prescribing or medical care.
Payment overview · 2025
We did not find matching Open Payments records for this doctor in the selected program year.
Separate record types
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Analysis 1 · Payment-linked products
No payment-linked product analysis is available because no matching General Payment records were found for the selected year.
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
There is no payer-company set available for this comparison.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Eliquis | Apixaban | 328 | 35 |
| Gabapentin | Gabapentin | 283 | 42 |
| Atorvastatin Calcium | Atorvastatin Calcium | 280 | 61 |
| Levothyroxine Sodium | Levothyroxine Sodium | 274 | 63 |
| Metoprolol Tartrate | Metoprolol Tartrate | 219 | 46 |
| Lisinopril | Lisinopril | 206 | 27 |
| Metoprolol Succinate | Metoprolol Succinate | 206 | 32 |
| Mirtazapine | Mirtazapine | 203 | 39 |
| Potassium Chloride | Potassium Chloride | 187 | 47 |
| Januvia | Sitagliptin Phosphate | 153 | 11 |
| Amlodipine Besylate | Amlodipine Besylate | 151 | 37 |
| Tamsulosin Hcl | Tamsulosin Hcl | 136 | 26 |
| Furosemide | Furosemide | 135 | 36 |
| Trazodone Hcl | Trazodone Hcl | 128 | 29 |
| Clopidogrel | Clopidogrel Bisulfate | 116 | 23 |
| Sertraline Hcl | Sertraline Hcl | 116 | 24 |
| Bumetanide | Bumetanide | 115 | 20 |
| Montelukast Sodium | Montelukast Sodium | 112 | 13 |
| Spironolactone | Spironolactone | 112 | 22 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 110 | 25 |
| Hydralazine Hcl | Hydralazine Hcl | 106 | 21 |
| Levetiracetam | Levetiracetam | 91 | 17 |
| Duloxetine Hcl | Duloxetine Hcl | 87 | 14 |
| Losartan Potassium | Losartan Potassium | 86 | 22 |
| Buspirone Hcl | Buspirone Hcl | 79 | 11 |
| Divalproex Sodium | Divalproex Sodium | 77 | 20 |
| Pravastatin Sodium | Pravastatin Sodium | 77 | suppressed |
| Famotidine | Famotidine | 74 | 20 |
| Finasteride | Finasteride | 73 | 11 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 70 | 16 |
| Simvastatin | Simvastatin | 66 | suppressed |
| Pantoprazole Sodium | Pantoprazole Sodium | 62 | 22 |
| Metformin Hcl | Metformin Hcl | 61 | 17 |
| Fluoxetine Hcl | Fluoxetine Hcl | 59 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 59 | 34 |
| Lactulose | Lactulose | 58 | suppressed |
| Prednisone | Prednisone | 57 | 23 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 56 | 30 |
| Allopurinol | Allopurinol | 55 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 55 | suppressed |
| Jardiance | Empagliflozin | 53 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 53 | 11 |
| Carvedilol | Carvedilol | 52 | 11 |
| Azithromycin | Azithromycin | 46 | 24 |
| Myrbetriq | Mirabegron | 46 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 44 | 24 |
| Methenamine Hippurate | Methenamine Hippurate | 44 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 43 | suppressed |
| Escitalopram Oxalate | Escitalopram Oxalate | 43 | 12 |
| Glimepiride | Glimepiride | 43 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 43 | suppressed |
| Latanoprost | Latanoprost | 41 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 40 | 11 |
| Xarelto | Rivaroxaban | 40 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 37 | 14 |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 35 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 35 | suppressed |
| Nystatin | Nystatin | 35 | 16 |
| Quetiapine Fumarate | Quetiapine Fumarate | 35 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 34 | 12 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 34 | suppressed |
| Clonazepam | Clonazepam | 33 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 33 | 15 |
| Budesonide | Budesonide | 32 | suppressed |
| Entresto | Sacubitril/Valsartan | 32 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 32 | suppressed |
| Omeprazole | Omeprazole | 31 | 13 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 31 | suppressed |
| Baclofen | Baclofen | 30 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 30 | suppressed |
| Movantik | Naloxegol Oxalate | 30 | suppressed |
| Ertapenem | Ertapenem Sodium | 29 | 14 |
| Citalopram Hbr | Citalopram Hydrobromide | 28 | suppressed |
| Glipizide | Glipizide | 28 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 27 | suppressed |
| Memantine Hcl | Memantine Hcl | 26 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 25 | suppressed |
| Clonidine | Clonidine | 25 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 25 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl/Pf | 25 | 18 |
| Digoxin | Digoxin | 24 | suppressed |
| Gentamicin Sulfate | Gentamicin Sulfate | 24 | 16 |
| Linzess | Linaclotide | 24 | suppressed |
| Rivastigmine | Rivastigmine | 24 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 23 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 23 | 13 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 22 | 12 |
| Klor-Con 10 | Potassium Chloride | 22 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 22 | suppressed |
| Ranolazine Er | Ranolazine | 21 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 21 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 20 | suppressed |
| Hydrochlorothiazide | Hydrochlorothiazide | 20 | suppressed |
| Meloxicam | Meloxicam | 20 | suppressed |
| Novolog Flexpen | Insulin Aspart | 20 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 19 | suppressed |
| Levofloxacin | Levofloxacin | 19 | 13 |
| Metformin Hcl Er | Metformin Hcl | 19 | suppressed |
| Nystop | Nystatin | 19 | suppressed |
| Restasis | Cyclosporine | 19 | suppressed |
| Timolol Maleate | Timolol Maleate | 19 | suppressed |
| Xifaxan | Rifaximin | 19 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 18 | suppressed |
| Carbamazepine Er | Carbamazepine | 18 | suppressed |
| Fentanyl | Fentanyl | 18 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 18 | suppressed |
| Olanzapine | Olanzapine | 18 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 18 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 17 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 17 | 12 |
| Fenofibrate | Fenofibrate Nanocrystallized | 17 | suppressed |
| Mupirocin | Mupirocin | 17 | 11 |
| Temazepam | Temazepam | 17 | suppressed |
| Topiramate | Topiramate | 17 | suppressed |
| Bupropion Xl | Bupropion Hcl | 16 | suppressed |
| Rybelsus | Semaglutide | 16 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 16 | suppressed |
| Cephalexin | Cephalexin | 15 | suppressed |
| Ketoconazole | Ketoconazole | 15 | suppressed |
| Lidocaine | Lidocaine | 15 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 15 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 14 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 14 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 14 | suppressed |
| Methotrexate | Methotrexate Sodium | 14 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 14 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 14 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 13 | suppressed |
| Nifedipine Er | Nifedipine | 13 | suppressed |
| Atenolol | Atenolol | 12 | suppressed |
| Biktarvy | Bictegrav/Emtricit/Tenofov Ala | 12 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 12 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 12 | suppressed |
| Celecoxib | Celecoxib | 12 | suppressed |
| Cilostazol | Cilostazol | 12 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 12 | suppressed |
| Dextrose 5%-0.45% Nacl | Dextrose 5 %-0.45 % Sod Chlord | 12 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 12 | suppressed |
| Klonopin | Clonazepam | 12 | suppressed |
| Lamotrigine | Lamotrigine | 12 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl | 12 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 12 | suppressed |
| Metolazone | Metolazone | 12 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 12 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 11 | suppressed |
| Brilinta | Ticagrelor | 11 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 11 | suppressed |
| Dulera | Mometasone/Formoterol | 11 | suppressed |
| Glucagon Emergency Kit | Glucagon | 11 | suppressed |
| Nuedexta | Dextromethorphan Hbr/Quinidine | 11 | suppressed |
Timeline
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | — | — | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error